MEAI

MEAI, also known as 5-methoxy-2-aminoindane (5-MeO-AI) and by its developmental code name CMND-100, is an entactogen-like psychoactive drug of the 2-aminoindane family. It is a cyclized phenethylamine and is the 2-aminoindane analogue of 3-methoxyamphetamine. The drug acts as a serotonin–norepinephrine releasing agent (SNRA) or as a modestly selective serotonin releasing agent (SSRA), with about 6-fold preference for induction of serotonin over norepinephrine release. MEAI has been encountered as a novel designer recreational drug. It is also under development for potential medical use in the treatment of alcoholism, cocaine use disorder, metabolic syndrome, and obesity.

Also known as: 5-methoxy-2-aminoindane, 5-MeO-AI, CMND-100, 5-Methoxy-2-indanamine

Classification

Chemical: Aminoindane
Chemical: Phenethylamine
Psychoactive: Entactogen
Psychoactive: Stimulant

Effects

Increased Heart Rate
Stimulation
Insomnia
Increased Perspiration
Nausea
Temporary Erectile Dysfunction
Talkativeness
Alertness Enhancement
Anxiety
Euphoria
Focus Enhancement
Thought Acceleration
Light Sensitivity
Appetite Suppression
Increased Music Appreciation
Dehydration
Tactile Enhancement
Open Eye Visuals

Routes of Administration

No route information available yet.

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

wikipedia.org

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu